Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Combination Aliskiren / Enalapril	2,354
Overall Study	STARTED	Aliskiren	2,356
Overall Study	STARTED	Enalapril	2,354
Overall Study	Full Analysis Set (FAS)	Combination Aliskiren / Enalapril	2,340
Overall Study	Full Analysis Set (FAS)	Aliskiren	2,340
Overall Study	Full Analysis Set (FAS)	Enalapril	2,336
Overall Study	Safety Set	Combination Aliskiren / Enalapril	2,347
Overall Study	Safety Set	Aliskiren	2,348
Overall Study	Safety Set	Enalapril	2,345
Overall Study	COMPLETED	Combination Aliskiren / Enalapril	1,567
Overall Study	COMPLETED	Aliskiren	1,524
Overall Study	COMPLETED	Enalapril	1,539
Overall Study	NOT COMPLETED	Combination Aliskiren / Enalapril	787
Overall Study	NOT COMPLETED	Aliskiren	832
Overall Study	NOT COMPLETED	Enalapril	815

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00853658/flow